Martin M Goldwyn insider trades: Hi Tech Pharmacal (HITK) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Martin reports to the SEC
Open-market buys and sales
15 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Oct 4, 2013 | HITK | ↓ Sell | 1,500 | $43.10 | $65K | Direct | Oct 8, 2013 (4d) |
| Sep 27, 2013 | HITK | ↓ Sell | 3,000 | $43.10 | $129K | Direct | Oct 1, 2013 (4d) |
| Jul 17, 2012 | HITK | ↓ Sell | 6,357 | $31.40 | $200K | Direct | Jul 17, 2012 (0d) |
| Oct 6, 2010 | HITK | ↓ Sell | 1,000 | $21.22 | $21K | Direct | Oct 7, 2010 (1d) |
| Sep 20, 2010 | HITK | ↓ Sell | 1,000 | $20.84 | $21K | Direct | Sep 20, 2010 (0d) |
| Sep 13, 2010 | HITK | ↓ Sell | 1,956 | $20.22 | $40K | Direct | Sep 15, 2010 (2d) |
| Jul 16, 2010 | HITK | ↓ Sell | 3,000 | $20.46 | $61K | Direct | Jul 20, 2010 (4d) |
| Apr 9, 2010 | HITK | ↓ Sell | 2,750 | $22.61 | $62K | Direct | Apr 9, 2010 (0d) |
| Sep 30, 2009 | HITK | ↓ Sell | 1,000 | $22.11 | $22K | Direct | Oct 1, 2009 (1d) |
| Sep 14, 2009 | HITK | ↓ Sell | 6,811 | $21.17 | $144K | Direct | Sep 15, 2009 (1d) |
| Mar 15, 2006 | HITK | ↓ Sell | 1,746 | $27.25 | $48K | Direct | Mar 17, 2006 (2d) |
| Jan 5, 2006 | HITK | ↓ Sell | 1,250 | $44.32 | $55K | Direct | Jan 9, 2006 (4d) |
| Sep 28, 2005 | HITK | ↓ Sell | 625 | $30.14 | $19K | Direct | Sep 30, 2005 (2d) |
| Sep 13, 2005 | HITK | ↓ Sell | 2,000 | $27.00 | $54K | Direct | Sep 15, 2005 (2d) |
| Jul 15, 2005 | HITK | ↓ Sell | 1,000 | $28.11 | $28K | Direct | Jul 19, 2005 (4d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Martin M Goldwyn's insider trades
Martin M Goldwyn is a director at Hi Tech Pharmacal (HITK). Since Jul 15, 2005, Martin has reported no open-market purchases and 15 sales worth $969K on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include option exercises (22 filings), other transactions (15 filings), grants and awards (8 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every HITK insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.